Competition between inside-out unfolding and pathogenic aggregation in an amyloid-forming β-propeller.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 38168102.
- Also identified by DOI 10.1038/s41467-023-44479-2 and PMC identifier 10762032.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Studies of folded-to-misfolded transitions using model protein systems reveal a range of unfolding needed for exposure of amyloid-prone regions for subsequent fibrillization. Here, we probe the relationship between unfolding and aggregation for glaucoma-associated myocilin. Mutations within the olfactomedin domain of myocilin (OLF) cause a gain-of-function, namely cytotoxic intracellular aggregation, which hastens disease progression. Aggregation by wild-type OLF (OLF<sup>WT</sup>) competes with its chemical unfolding, but only below the threshold where OLF loses tertiary structure. Representative moderate (OLF<sup>D380A</sup>) and severe (OLF<sup>I499F</sup>) disease variants aggregate differently, with rates comparable to OLF<sup>WT</sup> in initial stages of unfolding, and variants adopt distinct partially folded structures seen along the OLF<sup>WT</sup> urea-unfolding pathway. Whether initiated with mutation or chemical perturbation, unfolding propagates outward to the propeller surface. In sum, for this large protein prone to amyloid formation, the requirement for a conformational change to promote amyloid fibrillization leads to direct competition between unfolding and aggregation.
Medical subject headings
- Amyloid
- Glaucoma